M3CRC Colorectal Cancer Risk Test
M3CRC Colorectal Cancer Risk Assessment is a non-invasive, home-based stool sample test designed to support colorectal health risk assessment.
By analysing gut microbiome-related markers in a stool sample, the test helps assess the risk of colorectal cancer and colorectal polyps. The process does not require anaesthesia, colonoscopy or hospital-based sample collection. It may be suitable for individuals who value privacy, feel anxious about colonoscopy, or wish to start with an initial colorectal cancer risk assessment.
The test uses a simple home stool collection method. Once the sample is returned, laboratory analysis will be arranged, followed by a detailed report and relevant recommendations to help you better understand your bowel health.
Key Features of M3CRC
- Non-invasive testing: no colonoscopy, no anaesthesia, no wound and no pain
- Home sample collection: collect your sample conveniently at home
- High level of privacy: simple and discreet process to reduce embarrassment
- Clear risk assessment: helps assess risks related to colorectal cancer and polyps
- Suitable for those who are worried about colonoscopy: may be used as an initial health screening reference
- Detailed report: result explanation provided after testing
M3CRC may be suitable for:
- Adults aged 45 or above who are concerned about bowel health
- Individuals with a family history of colorectal cancer or related bowel conditions
- Individuals with irregular eating habits or high-stress lifestyles
- Individuals who wish to undergo regular colorectal cancer screening
- Individuals who are hesitant about colonoscopy
- Individuals interested in understanding their gut microbiome-related health markers


















